Ausgabe 1/2018
Inhalt (16 Artikel)
Interactions of lean soft-tissue and chemotherapy toxicities in patients receiving anti-cancer treatments
Jessica J. Hopkins, Michael B. Sawyer
Role of toll-like receptor 4 (TLR4)-mediated interleukin-6 (IL-6) production in chemotherapy-induced mucositis
S. Khan, Hannah R. Wardill, J. M. Bowen
Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancer
A. A. van Zweeden, C. J. van Groeningen, R. J. Honeywell, E. Giovannetti, R. Ruijter, C. H. Smorenburg, G. Giaccone, H. M. W. Verheul, G. J. Peters, Hans J. van der Vliet
Comparison of tumor size assessments in tumor growth inhibition-overall survival models with second-line colorectal cancer data from the VELOUR study
Laurent Claret, Christina Pentafragka, Sanja Karovic, Binsheng Zhao, Lawrence H. Schwartz, Michael L. Maitland, Rene Bruno
Timing is everything: intraperitoneal chemotherapy after primary or interval debulking surgery for advanced ovarian cancer
Jessica Lee, John P. Curtin, Franco M. Muggia, Bhavana Pothuri, Leslie R. Boyd, Stephanie V. Blank
Sunitinib does not acutely alter left ventricular systolic function, but induces diastolic dysfunction
Takeshi Wada, Kentaro Ando, Atsuhiko T. Naito, Yuji Nakamura, Ai Goto, Koki Chiba, Nur Jaharat Lubna, Xin Cao, Mihoko Hagiwara-Nagasawa, Hiroko Izumi-Nakaseko, Yuji Nakazato, Atsushi Sugiyama
Exposure–response relationship for ramucirumab from the randomized, double-blind, phase 3 REVEL trial (docetaxel versus docetaxel plus ramucirumab) in second-line treatment of metastatic non-small cell lung cancer
Egbert F. Smit, Edward B. Garon, Martin Reck, Federico Cappuzzo, Paolo Bidoli, Roger B. Cohen, Ling Gao, Lisa M. O’Brien, Pablo Lee, Annamaria Zimmermann, David R. Ferry, Allen S. Melemed, Maurice Pérol
UGT1A polymorphisms associated with worse outcome in colorectal cancer patients treated with irinotecan-based chemotherapy
Qianqian Yu, Tao Zhang, Conghua Xie, Hong Qiu, Bo Liu, Liu Huang, Ping Peng, Jueping Feng, Jigui Chen, Aihua Zang, Xianglin Yuan
Expression of M2 macrophage markers YKL-39 and CCL18 in breast cancer is associated with the effect of neoadjuvant chemotherapy
Nikolai Litviakov, Matvey Tsyganov, Irina Larionova, Marina Ibragimova, Irina Deryusheva, Polina Kazantseva, Elena Slonimskaya, Irina Frolova, Eugeniy Choinzonov, Nadezhda Cherdyntseva, Julia Kzhyshkowska
Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for untreated non-squamous non-small-cell lung cancer
Taro Koba, Seigo Minami, Yu Nishijima-Futami, Kentaro Masuhiro, Hiromi Kimura, Shinji Futami, Moto Yaga, Masahide Mori, Hiroyuki Kagawa, Takeshi Uenami, Satoshi Kohmo, Tomoyuki Otsuka, Suguru Yamamoto, Kiyoshi Komuta, Takashi Kijima
Efficacy and safety of cytotoxic drug chemotherapy after first-line EGFR–TKI treatment in elderly patients with non-small-cell lung cancer harboring sensitive EGFR mutations
Hisao Imai, Hiroyuki Minemura, Tomohide Sugiyama, Yutaka Yamada, Kyoichi Kaira, Kenya Kanazawa, Takashi Kasai, Takayuki Kaburagi, Koichi Minato
Exposure–response analysis of alectinib in crizotinib-resistant ALK-positive non-small cell lung cancer
Peter N. Morcos, Eveline Nueesch, Felix Jaminion, Elena Guerini, Joy C. Hsu, Walter Bordogna, Bogdana Balas, Francois Mercier
LAPTM4B gene copy number gain is associated with inferior response to anthracycline-based chemotherapy in hormone receptor negative breast carcinomas
Orsolya Rusz, Orsolya Papp, Laura Vízkeleti, Béla Ákos Molnár, Kristóf Csaba Bende, Gábor Lotz, Balázs Ács, Zsuzsanna Kahán, Tamás Székely, Ágnes Báthori, Csilla Szundi, Janina Kulka, Zoltán Szállási, Anna-Mária Tőkés
Possible association of CAG repeat polymorphism in KCNN3 encoding the potassium channel SK3 with oxaliplatin-induced neurotoxicity
Benjamin Anon, Bérenger Largeau, Alban Girault, Aurélie Chantome, Morgane Caulet, Clémence Perray, Driffa Moussata, Christophe Vandier, Chantal Barin-Le Guellec, Thierry Lecomte
Bioequivalence study of single-dose lenalidomide capsule vs. Revlimid® capsule in healthy Chinese males
Jin Wang, Lu Qi, Zejuan Wang, Gang Chen, Chen Liu, Ying Liu, Xiaona Liu, Yu Wang, Chunpu Lei, Xinghe Wang
Reduced dose pegfilgrastim is associated with less bone pain without increased neutropenia: a retrospective study
Elyse E. Lower, Mahmoud Charif, Meg Bartelt